| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 05/24/2012 | US20120128585 Method of Diagnosing the presence of a tumor in a mammal by assessing CDO expression level |
| 05/24/2012 | US20120128584 Anti-cdh3 antibodies labeled with radioisotope label and uses thereof |
| 05/24/2012 | US20120128580 Preselection of subjects for therapeutic treatment with elesclomol based on hypoxic status |
| 05/24/2012 | CA2818583A1 Novel conjugates for targeted drug delivery |
| 05/24/2012 | CA2818561A1 Regimens for treatments using anti-igf antibodies |
| 05/24/2012 | CA2818544A1 Method of treatment with braf inhibitor |
| 05/24/2012 | CA2818389A1 Substituted 4-(selenophen-2(or 3)-ylamino)pyrimidine compounds and methods of use thereof |
| 05/24/2012 | CA2818361A1 3'-deutero-pomalidomide |
| 05/24/2012 | CA2818234A1 Generation of neural stem cells from human trophoblast stem cells |
| 05/24/2012 | CA2818229A1 Pharmaceutical combination of paclitaxel and a cdk inhibitor |
| 05/24/2012 | CA2818163A1 Method of treating hematological cancers |
| 05/24/2012 | CA2817982A1 Controlled release mucoadhesive systems |
| 05/24/2012 | CA2817957A1 Substance for increasing the production of a specific acyl-chain dihydroceramide(s) for improving the effectiveness of cancer treatments |
| 05/24/2012 | CA2817846A1 Use of prolactin receptor antagonist and chemotherapeutic drug for treating ovarian cancer |
| 05/24/2012 | CA2817842A1 Combination therapy for b cell lymphomas |
| 05/24/2012 | CA2817583A1 Treatment of cancer with elevated dosages of soluble fgfr1 fusion proteins |
| 05/24/2012 | CA2817564A1 Preselection of subjects for therapeutic treatment based on hypoxic status |
| 05/24/2012 | CA2817537A1 Fgfr1 extracellular domain combination therapies |
| 05/24/2012 | CA2817536A1 Method for treating breast cancer and ovarian cancer |
| 05/24/2012 | CA2817355A1 Methods and compositions for modulating pd1 |
| 05/24/2012 | CA2817133A1 Methods of treating tumors |
| 05/24/2012 | CA2817093A1 Nampt inhibitors |
| 05/24/2012 | CA2816997A1 Novel polymer derivative of cytidine metabolic antagonist |
| 05/24/2012 | CA2816810A1 Crystalline form of an inhibitor of mdm2/4 and p53 interaction |
| 05/24/2012 | CA2816679A1 3-(aminoaryl)-pyridine compounds |
| 05/24/2012 | CA2816594A1 Nampt and rock inhibitors |
| 05/24/2012 | CA2816144A1 Quinoline derivatives as pik3 inhibitors |
| 05/23/2012 | EP2455469A1 Nucleic acid molecule capable of binding to hmgb1, and use thereof |
| 05/23/2012 | EP2455467A1 Double-stranded oligonucleotides |
| 05/23/2012 | EP2455403A1 Homogeneous humanized antibodies against JAM-A that inhibit proliferation |
| 05/23/2012 | EP2455382A1 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors |
| 05/23/2012 | EP2455379A1 Crystals of pyrroloquinolinequinone sodium salts |
| 05/23/2012 | EP2455378A1 Carbazole and carboline derivatives, and preparation and therapeutic applications thereof |
| 05/23/2012 | EP2455375A2 Diacylhydrazine ligands for modulating the expression of exogenous genes in mammalian systems via an ecdysone receptor complex |
| 05/23/2012 | EP2455369A1 Derivatives of 2-aryl-4-quinolones having an aminoalkyl group as anticancer agents |
| 05/23/2012 | EP2455368A1 2-[[[2-[(hydroxyacetyl)amino]-4-pyridinyl]methyl]thio]-n-[4-(trifluoromethoxy)phenyl]-3-pyridinecarboxamide benzene- sulfonate, crystals of same, polymorphs thereof, and processes for production thereof |
| 05/23/2012 | EP2455103A1 Anti-cancer agent, method for inducing apoptosis of cancer cells, and method for screening for anti-cancer agent |
| 05/23/2012 | EP2455102A1 Cancer therapeutic agent comprising antibody against cancer-specific membrane antigen |
| 05/23/2012 | EP2454276A1 Therapeutic agents |
| 05/23/2012 | EP2454266A1 9e-15-(2-pyrrolidin-1-yl-ethoxy)-7,12,25-trioxa-19,21,24-triaza- tetracyclo[18.3.1.1(2,5).1(14)18)]hexacosa-1(24),2,4,9,14,16,18(26),20,22-nonaene citrate salt |
| 05/23/2012 | EP2454263A1 3-hydroxypyrrolidine inhibitors of 5'-methylthioadenosine phosphorylase and nucleosidase |
| 05/23/2012 | EP2454262A1 Pyrrolopyrazine inhibitors of kinases |
| 05/23/2012 | EP2454258A1 Heterocyclic compounds as autotaxin inhibitors |
| 05/23/2012 | EP2454257A1 Pyrrolopyridine inhibitors of kinases |
| 05/23/2012 | EP2454253A1 Aminopyridine derivatives for treating tumors and inflammatory diseases |
| 05/23/2012 | EP2454238A1 Crystalline forms of n-[3-fluoro-4-({6-(methyloxy)-7-[(3-morpholin-4-ylpropyl)oxy]-quinolin-4-yl}oxy)phenyl]-n'-(4-fluorophenyl)cyclopropane-1, 1-dicarboxamide |
| 05/23/2012 | EP2454237A1 3-0x0-2, 3, -dihydro-1h-isoindole-4-carboxamides with selective parp-1 inhibition |
| 05/23/2012 | EP2454236A1 3-oxo-2, 3-dihydro-1h-isoindole-4-carboxamides as parp inhibitors |
| 05/23/2012 | EP2453919A1 Antibodies directed to gpnmb and uses thereof |
| 05/23/2012 | EP2453892A1 Compounds and methods for the treatment of cancer |
| 05/23/2012 | EP2241569B1 Thienopyridazine compounds, their preparations, pharmaceutical compositions and uses |
| 05/23/2012 | EP2046740B1 Compounds having crth2 antagonist activity |
| 05/23/2012 | EP2036903B1 Potentiator of radiation therapy |
| 05/23/2012 | EP1930017B1 Composition effective for prevention and treatment of adult disease |
| 05/23/2012 | EP1567641B1 Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer |
| 05/23/2012 | EP1474408B1 N-phenyl-2-pyrimidine-amine derivatives |
| 05/23/2012 | EP1446418B1 Integrin targeting compounds |
| 05/23/2012 | EP1346059B1 Photochemical internalization for delivery of molecules into the cytosol |
| 05/23/2012 | CN1961897B Method for verifying pomegranate rind extract |
| 05/23/2012 | CN1938264B Acid addition salts of 5-aminolevulinic acid or its derivatives |
| 05/23/2012 | CN1898267B Modified anti-cd52 antibody |
| 05/23/2012 | CN1659288B Pharmaceutical composition for preventing or reducing DNA damage |
| 05/23/2012 | CN102471380A Anti-fcrh5 antibodies and immunoconjugates and methods of use |
| 05/23/2012 | CN102471371A 用于肿瘤血管系统的归巢肽 Homing peptides for tumor vasculature |
| 05/23/2012 | CN102471369A 肽类化合物及其用途 Peptide compounds and their uses |
| 05/23/2012 | CN102471351A 用作pi3k抑制剂的2-羧酰胺环氨基脲 Used as pi3k inhibitor 2- carboxamide ring semicarbazide |
| 05/23/2012 | CN102471345A 激酶的吡咯并吡嗪抑制剂 Kinase inhibitors pyrrolopyrazine |
| 05/23/2012 | CN102471343A 作为自分泌运动因子抑制剂的杂环化合物 Heterocyclic compounds as inhibitors of autocrine motility factor |
| 05/23/2012 | CN102471339A 激酶的吡咯并吡啶抑制剂 Kinase inhibitors pyrrolopyridine |
| 05/23/2012 | CN102471338A 新的氮杂杂环化合物 The new aza-heterocyclic compounds |
| 05/23/2012 | CN102471336A 吡咯并喹啉醌的钠盐结晶 Pyrrolo-quinoline quinone and the crystalline sodium salt of |
| 05/23/2012 | CN102471335A Azabicyclo compound and salt thereof |
| 05/23/2012 | CN102471332A 取代的2-甲酰胺环氨基脲类 Substituted 2-amino-lactam ring ureas |
| 05/23/2012 | CN102471329A Furazanobenzimidazoles as prodrugs to treat neoplastic or autoimmune diseases |
| 05/23/2012 | CN102471319A Jnk的抑制剂 Jnk inhibitors |
| 05/23/2012 | CN102471317A 用于治疗肿瘤和炎性疾病的氨基吡啶衍生物 For the treatment of cancer and inflammatory diseases aminopyridine derivative |
| 05/23/2012 | CN102471310A 用于治疗增生性疾病的联吡啶化合物 For the treatment of proliferative diseases bipyridyl compound |
| 05/23/2012 | CN102471300A 用于增强病毒效力的组合物和方法 Compositions and methods for enhancing the effectiveness of the virus |
| 05/23/2012 | CN102471280A 吡唑衍生物、其制备及其治疗用途 Pyrazole derivatives, their preparation and their therapeutic use |
| 05/23/2012 | CN102471273A 2-[[[2-[(羟基乙酰基)氨基]-4-吡啶基]甲基]硫代]-n-[4-(三氟甲氧基)苯基]-3-吡啶甲酰胺苯磺酸盐、其晶体、其多晶型物以及用于制备其的方法 2 - [[[2 - [(hydroxy acetyl) amino] -4-pyridyl] methyl] thio] -n- [4- (trifluoromethoxy) phenyl] -3-pyridinecarboxamide benzene sulfonates, crystal, polymorph thereof, and a method for the preparation thereof |
| 05/23/2012 | CN102471260A Novel benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics |
| 05/23/2012 | CN102470184A 采用放射性种子的肿瘤治疗 Cancer treatment using radioactive seeds |
| 05/23/2012 | CN102470174A 抗癌剂、癌细胞的凋亡诱导方法及抗癌剂的筛选方法 Anticancer agent, apoptosis-inducing anticancer agent and a method of cancer screening method |
| 05/23/2012 | CN102470173A 金属纳米粒子、其制备和应用 Metal nanoparticles, their preparation and use |
| 05/23/2012 | CN102470172A Combination therapy of an afucosylated CD20 antibody with fludarabine and/or mitoxantrone |
| 05/23/2012 | CN102470136A Plk 抑制剂的盐类 Plk inhibitors salts |
| 05/23/2012 | CN102470133A Quinoline derivative-containing pharmaceutical composition |
| 05/23/2012 | CN102470129A 作为药物使用的组合制剂 Drug use as a combined preparation |
| 05/23/2012 | CN102465125A 一种靶向golph3基因干扰小分子rna及其抗胶质瘤迁移的用途 One kind of gene targeting golph3 rna interference and small molecule anti-glioma migration purposes |
| 05/23/2012 | CN102464725A 一种天麻多糖及其降解产物,其制备方法和应用 One kind of Gastrodia elata and its degradation products, their preparation and use |
| 05/23/2012 | CN102464720A 抗血管抑素受体人鼠嵌合单克隆抗体制备及其应用 Anti-angiostatin receptor chimeric monoclonal antibody and its application |
| 05/23/2012 | CN102464702A 制备醋酸亮丙瑞林的方法、产品及用途 Leuprolide preparation methods, products and uses |
| 05/23/2012 | CN102464688A 胸苷环磷酸酯化合物及其抗肿瘤用途 Thymidine cyclic phosphate compounds and their use of anti-tumor |
| 05/23/2012 | CN102464680A 羟亚甲基桥连的Neu5Ac-α（2→6）-Gal碳苷及其纳米金粒子的合成方法 Hydroxyl methylene-bridged Neu5Ac-α (2 → 6) -Gal C-glycosides and synthetic method of gold nanoparticles |
| 05/23/2012 | CN102464675A Gold complexes with antitumor activity and pharmaceutically-acceptable derivatives thereof |
| 05/23/2012 | CN102464667A 一类五元杂环并嘧啶类化合物及其制备方法和用途 A class of five-membered heterocyclic pyrimidine compounds and their preparation and use |
| 05/23/2012 | CN102464664A 一种双内酯类衍生物及其制备方法和应用 A two inner ester derivatives, preparation method and application |
| 05/23/2012 | CN102464652A Imidazole derivative and preparation method as well application |
| 05/23/2012 | CN102464639A 麦考酚酸钠的新晶型及其制备方法 The new crystal form and its preparation method mycophenolate sodium |
| 05/23/2012 | CN102464634A 一种三尖杉内生真菌次生代谢产物中的新化合物及其制备方法和用途 A three Cephalotaxaceae endophyte secondary metabolites of new compounds and their preparation and use |